Companies Investors People

Drop to look up

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
Alternatives

For iPhone and iPad

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Dealroom, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Terms of service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Library

Nucleo

Agentic platform automating CT scan analysis for oncology care and clinical research.

: 2
: 2025
: San Francisco, CA, USUnited States
: Y Combinator F25

Nucleo Website, Blog & Press Pages - aVenture Research

Library

nucleoresearch.comCrawled Sep 25, 2026

Topics

Publication type

Search the library

Content origin

Row density

Homepage

1 page

Homepage/
Advanced AI for oncological medical imaging. From scan to answer. In seconds, not hours.

Coverage

5 items

Nucleo at ASCO 2026 in Chicagolinkedin.com/posts/nucleoresearch_we-are-at-asco-2026-in-chicago-come-find-activity-7466499767418785792-PuU6
Nucleo announced it would attend ASCO 2026 in Chicago and invited the oncology community to visit booth IH21.
May 2026LinkedInNews article
Nucleo cofounder Angelica Iacovelli named to Forbes 30 Under 30linkedin.com/posts/angelica-iacovelli-490a8a1a7_today-i-found-out-i-made-the-forbes-30-under-activity-7449846476597329921-OQCS
Nucleo CEO and co-founder Angelica Iacovelli is named to Forbes 30 Under 30. The recognition notes the company's progress from idea to hospital deployments and joining Y Combinator within a year.
Apr 2026LinkedInNews article
We're hiring: Chief of Staff to the CEOlinkedin.com/posts/angelica-iacovelli-490a8a1a7_were-hiring-nucleo-yc-f25-is-building-activity-7422311615045373952-Y_yW
Nucleo is hiring a Chief of Staff to the CEO to help scale execution across product, sales, fundraising, and operations. The role is framed around supporting execution across those functions as the company scales; the post does not specify qualifications, location, or additional responsibilities.
Mar 2026LinkedInNews article
We've graduated again!linkedin.com/posts/angelica-iacovelli-490a8a1a7_weve-graduated-again-we-recently-had-y-activity-7406382742894104576-Wg5G
Nucleo says it has completed Y Combinator Demo Day, where its founders presented the company to more than 1,000 investors and industry leaders. The post describes this as the company’s latest graduation but does not provide details about its product, funding, or investor response.
Dec 2025LinkedInNews article